Microbial interactions in the respiratory tract

Pediatric Infectious Disease Journal

Volumn 28, Issue 10 SUPPL., 2009, Pages

  Murphy, Timothy F ^a,b,f   Bakaletz, Lauren O ^c,d   Smeesters, Pierre R ^e  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^f Buffalo VAMC151 ^*  (United States)

Author keywords

Bacterial interactions; Biofilm; Heptavalent pneumococcal conjugate vaccine; Moraxella catarrhalis; Nasopharyngeal flora; Nontypeable haemophilus influenzae; Otitis media; Pathogenesis; Polymicrobial disease; Serotype replacement; Streptococcus pneumoniae; Upper respiratory tract; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; BIOFILM; CELLULITIS; CHILD; CHILDHOOD DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONJUNCTIVITIS; EPIGLOTTITIS; HAEMOPHILUS INFLUENZAE; HUMAN; MORAXELLA CATARRHALIS; NASOPHARYNX; OTITIS MEDIA; PATHOGENESIS; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; SINUSITIS; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION; WATCHFUL WAITING;

EID: 70350443014     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181b6d7ec     Document Type: Article

References (71)

1. 1. De Lencastre H, Tomasz A. From ecological reservoir to disease: the nasopharynx, day-care centres and drug-resistant clones of Streptococcus pneumoniae. J Antimicrob Chemother. 2002;50(suppl S2):75-81. (Pubitemid 36175840)
2. Garcia-Rodriguez JA, Fresnadillo Martinez MJ. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J Antimicrob Chemother. 2002;50(suppl S2):59-73.
3. 3. Faden H, Duffy L, Williams A, et al. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first two years of life. Acta Otolaryngol Suppl. 1996;523:128-129. (Pubitemid 26130565)
4. Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J Infect Dis. 1997;175:1440-1445.
5. Faden H, Duffy L, Williams A, et al. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first 2 years of life. J Infect Dis. 1995;172:132-135.
6. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-1465.
7. 7. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989; 160:83-94. (Pubitemid 19162997)
8. 8. Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr. 2001;160:407-413. (Pubitemid 32662358)
9. 9. Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis. 2006;43:1417-1422. (Pubitemid 44845642)
10. 10. Arguedas A, Dagan R, Leibovitz E, et al. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection. Pediatr Infect Dis J. 2006;25:211-218. (Pubitemid 43379060)
11. 11. Kilpi T, Herva E, Kaijalainen T, et al. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J. 2001;20:654-662. (Pubitemid 32652315)
12. Gehanno P, Panajotopoulos A, Barry B, et al. Microbiology of otitis media in the Paris, France, area from. 1987 to 1997. Pediatr Infect Dis J. 2001;20:570-573.
13. 13. Aspin MM, Hoberman A, McCarty J, et al. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J Pediatr. 1994;125:136-141. (Pubitemid 24225196)
14. Faden H, Bernstein J, Brodsky L, et al. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol. 1992;101: 87-91.
15. Del Beccaro MA, Mendelman PM, Inglis AF, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992;120:81-84.
16. Chonmaitree T, Owen MJ, Patel JA, et al. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr. 1992;120:856-862.
17. 17. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23:829-833. (Pubitemid 40221025)
18. Fedson DS, Musher DM. Pneumococcal vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. 2nd ed. Philadelphia, PA: W.B. Saunders Company; 1994:517-564.
19. 19. Cartwright K. Pneumococcal, disease in western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr. 2002;161:188-195. (Pubitemid 34253335)
20. Kamerling JP. Pneumococcal polysaccharide: A chemical view. In: Tomasz A, ed. Streptococcus Pneumoniae: Molecular Biology and Mechanisms of Disease. New York, NY: Mary Ann Liebert; 2000:81-114.
21. Kaltoft MS, Skov Sorensen UB, Slotved HC, et al. An easy method for detection of nasopharyngeal carriage of multiple Streptococcus pneumoniae serotypes. J Microbiol Methods. 2008;75:540-544.
22. 22. Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30:100-121. (Pubitemid 30067069)
23. 23. Hausdorff WP, Bryant J, Kloek C, et al. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis. 2000; 30:122-140. (Pubitemid 30067070)
24. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005;5:83-93.
25. Rubin LG, Moxon ER. Pathogenesis of bloodstream invasion with Haemophilus influenzae type b. Infect Immun. 1983;41:280-284.
26. Foxwell AR, Kyd JM, Cripps AW. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev. 1998;62:294-308.
27. Musser JM, Barenkamp SJ, Granoff DM, et al. Genetic relationships of serologically nontypeable and serotype b strains of Haemophilus influenzae. Infect Immun. 1986;52:183-191.
28. 28. Porras O, Caugant DA, Gray B, et al. Difference in structure between type b and nontypeable Haemophilus influenzae populations. Infect Immun. 1986;53:79-89. (Pubitemid 16084367)
29. Murphy TF. Vaccine development for nontypeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Expert Rev Vaccines. 2005;4:843-853.
30. Rovers MM, Schilder AG, Zielhuis GA, et al. Otitis media. Lancet. 2004;363:465-473.
31. Lim DJ, DeMaria TF, Bakaletz LO. Functional morphology of the tubotympanum related to otitis media.: a review. Am J Otol. 1987;8:385-389.
32. Faden H, Waz MJ, Bernstein JM, et al. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol. 1991;100:612-615.
33. 33. Farjo RS, Foxman B, Patel MJ, et al. Diversity and sharing of Haemophilus influenzae strains colonizing healthy children attending day-care centers. Pediatr Infect Dis J. 2004;23:41-46. (Pubitemid 38176760)
34. 34. Revai K, McCormick DP, Patel J, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media. Pediatrics. 2006; 117:1823-1829. (Pubitemid 46071418)
35. Murphy TF. Respiratory infections caused by non-typeable Haemophilus influenzae. Curr Opin Infect Dis. 2003;16:129-134.
36. Friedlaender MH. A review of the causes and treatment of bacterial and allergic conjunctivitis. Clin Ther. 1995;17:800-810; discussion 779.
37. Abman SH, Ogle JW, Harbeck RJ, et al. Early bacteriologie, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr. 1991;119:211-217.
38. May JR. The bacteriology of chronic bronchitis. Lancet. 1953;265:534-537.
39. 39. Murphy TF, Brauer AL, Grant BJ, et al. Moraxella catarrhalis in chronic obstructive pulmonar,' disease: burden of disease and immune response. Am J Respir Crit Care Med. 2005;172:195-199. (Pubitemid 40981193)
40. Brunstein JD, Cline CL, McKinney S, et al. Evidence from multiplex molecular assays for complex multipathogen interactions in acute respiratory infections. J Clin Microbiol. 2008;46:97-102.
41. 41. Jacoby P, Watson K, Bowman J, et al. Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract. Vaccine. 2007;25:2458-2464. (Pubitemid 46366126)
42. Pettigrew MM, Gent JF, Revai K, et al. Microbial interactions during upper respiratory tract infections. Emerg Inject Dis. 2008;14:1584-1591.
43. 43. Pericone CD, Overweg K, Hermans PW, et al. Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun. 2000;68: 3990-3997. (Pubitemid 30434551)
44. Shakhnovich EA, King SJ, Weiser JN. Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm, for interbacterial competition among pathogens of the human respiratory tract. Infect Immun. 2002;70:7161-7164.
45. Lysenko ES, Ratner AJ, Nelson AL, et al. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog. 2005;1:e1.
46. 46. Lysenko ES, Clarke TB, Shchepetov M, et al. Nodl signaling overcomes resistance of S. pneumoniae to opsonophagocytic killing. PLoS Pathog. 2007;3:e118. (Pubitemid 47359085)
47. Bakaletz LO. Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol. 1995;3:110-114.
48. 48. Avadhanula V, Rodriguez CA, Devincenzo JP, et al. Respiratory virases augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol. 2006;80:1629-1636. (Pubitemid 43228704)
49. 49. Smith CB, Golden C, Klauber MR, et al. Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis. 1976; 134:552-561. (Pubitemid 8015072)
50. 50. Tong HH, Fisher LM, Kosunick GM, et al. Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla. Ann Otol Rhinol Laryngol. 2000; 109:1021-1027. (Pubitemid 30835803)
51. 51. Tong HH, James M, Grants I, et al. Comparison of structural changes of cell surface carbohydrates in the eustachian tube epithelium of chinchillas infected with a. Streptococcus pneumoniae neuraminidase-deficient mutant or its isogenic parent strain. Microb Pathog. 2001;31:309-317. (Pubitemid 34084422)
52. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23:S87-S97.
53. 53. Speshock JL, Doyon-Reale N, Rabah R, et al. Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun. 2007;75: 3102-3111. (Pubitemid 46870196)
54. Moxon ER, Sweetman WA, Deadman ME, et al. Haemophilus influenzae biofilms: hypothesis or fact? Trends Microbiol. 2008;16:95-100.
55. 55. Post JC, Hiller NL, Nistico L, et al. The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg. 2007; 15: 347-351. (Pubitemid 47373982)
56. Post JC, Stoodley P, Hall-Stoodley L, et al. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg. 2004; 12:185-190.
57. 57. Slinger R, Chan F, Ferris W, et al. Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms. Diagn Microbiol Infect Dis. 2006;56:247-253. (Pubitemid 44648594)
58. 58. Rayner MG, Zhang Y, Gorry MC, et al. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA. 1998;279: 296-299. (Pubitemid 28071021)
59. 59. Stamer TD, Zhang N, Kim G, et al. Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis. Am J Respir Crit Care Med. 2006;174:213-220. (Pubitemid 44015395)
60. Allegrucci M, Hu FZ, Shen K, et al. Phenotypic characterization of Streptococcus pneumoniae biofilm development. J Bacterial. 2006; 188: 2325-2335.
61. Pearson MM, Laurence CA, Guinn SE, et al. Biofilm formation by Moraxella catarrhalis in vitro: roles of the UspA1 adhesin and the Hag hemagglutinin. Infect Immun. 2006;74:1588-1596.
62. 62. Jurcisek J, Greiner L, Watanabe H, et al. Role of sialic acid and complex carbohydrate biosynthesis in biofilm formation by nontypeable Haemophilus influenzae in the chinchilla middle ear. Infect Immun. 2005;73:3210-3218. (Pubitemid 40745860)
63. 63. Murphy TF, Kirkham C. Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol. 2002;2:7. (Pubitemid 38994394)
64. 64. Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296:202-211. (Pubitemid 44050374)
65. Starner TD, Shrout JD, Parsek MR, et al. Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and diminish established biofilms. Antimicrob Agents Chemother. 2008;52:137-145.
66. Kaji C, Watanabe K, Apicella MA, et al. Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms. Tohoku J Exp Med. 2008;214:121-128.
67. 67. Barakate M, Beckenham E, Curotta J, et al. Bacterial biofilm adherence to middle-ear ventilation tubes: scanning electron micrograph images and literature review. J Laryngol Otol. 2007;121:993-997. (Pubitemid 351650454)
68. Jang CH, Cho YB, Choi CH. Structural features of tympanostomy tube biofilm formation in ciprofloxacin-resistant Pseudomonas otorrhea. Int J Pediatr Otorhinolaryngol. 2007;71:591-595.
69. 69. Vlastarakos PV, Nikolopoulos TP, Korres S, et al. Grommets in otitis media with effusion: the most frequent operation in children. But is it associated with significant complications? Eur J Pediatr. 2007;166:385-391. (Pubitemid 46450495)
70. Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec. 1999; 74:177-183.
71. 71. Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and nontypeable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006; 367:740-748. (Pubitemid 43326292)